Full Year 2024 Ucb SA Earnings Call Transcript

Author's Avatar
Feb 27, 2025

Feb 27, 2025 / 01:00PM GMT
Antje Witte - Ucb SA - Head of Investor Relations

Welcome to the UCB full year 2024 Capital Market Call. My name is Antje. I'm the Head of Investor Relations at UCB. Before I introduce you to the agenda and hand over to the speakers today, I'd like to make some remarks. This video conference is being recorded.

You can find the presentation in our download center on our website if you dial-in by phone. The presentation and the following Q&A session are intended for institutional capital market participants only. If you're not, please disconnect now. This presentation and the following Q&A session are covered by the disclaimer and the full harbor statement as stated on slide 2 of the slide deck. Please read this carefully.

With this, I'd like you to introduce you to our speakers for today. Our CEO, Jean-Christophe Tellier; Emmanuel Caeymaex, Chief Commercial Operating Officer; our CFO, Sandrine Dufour. And in the Q&A session, they will be joined by Alistair Henry, our Chief Scientific Officer; and Fiona du Monceau, Head of Patient Evidence.

With this, Jean-Christophe,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot